Moreover, we also demonstrate that the LRP6-Wnt-β-catenin signaling partially regulates the expression of REST and cooperatively maintains the morphological integrity and viability of neurons exposed to PrP106-126, thus suggesting REST and this novel signaling pathway could be a particularly attractive therapeutic target of prion diseases. Here, REST is linked to prion disease.